Trial intelligence / Profile preview

Ivabradine IV bolus and infusion after PCI for ST-elevation myocardial infarction

2005-005122-31Phase 2Completed

Sponsor
Institut de Recherches Internationales Servier
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Ivabradine IV regimen with Placebo IV regimen (2 arms). Primary endpoints: Cardiac parameters, Safety and tolerability and 1 more. Started Mar 2006; status: completed.

02

Drugs

ivabradine
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2005-005122-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005122-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call